12:00 AM
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Flocor: Completed Phase III study enrollment

CytRx Corp. (CYTR), Norcross, Ga.
Product: Flocor
Business: Hematology
Therapeutic category: Cell adhesion
Target: Red...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >